Per-oral endoscopic pyloromyotomy (G-POEM) for the treatment of gastroparesis - a pilot single-centre study with mid-term follow-up

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F20%3A00079683" target="_blank" >RIV/00023001:_____/20:00079683 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/20:10411890

Výsledek na webu

<a href="https://www.prolekare.cz/casopisy/rozhledy-v-chirurgii/2020-3-2/peroralni-endoskopicka-pyloromyotomie-g-poem-v-terapii-gastroparezy-pilotni-studie-se-stredne-dlouhym-sledovanim-122063" target="_blank" >https://www.prolekare.cz/casopisy/rozhledy-v-chirurgii/2020-3-2/peroralni-endoskopicka-pyloromyotomie-g-poem-v-terapii-gastroparezy-pilotni-studie-se-stredne-dlouhym-sledovanim-122063</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.33699/PIS.2020.99.3.116-123" target="_blank" >10.33699/PIS.2020.99.3.116-123</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Per-oral endoscopic pyloromyotomy (G-POEM) for the treatment of gastroparesis - a pilot single-centre study with mid-term follow-up

Popis výsledku v původním jazyce

Introduction: Endoscopic pyloromyotomy (G-POEM) is an emerging therapeutic method for the treatment of gastroparesis (GP). So far, only limited case-series suggesting its effectivity have been published. The aim of our study was to assess the effectivity of G-POEM in patients with refractory GP. Methods: Consecutive patients with severe and refractory GP were offered the procedure. An abnormal gastric emptying study (GES) was necessary for inclusion. The main outcome was treatment success defined as a decrease of the total GSCI symptom score by at least 40% from baseline at 3, 6, 12 and 24 months. Results: G-POEM was performed in 9 patients (5 women, mean age 56.3): 5 post-surgical, 2 diabetic, 1 idiopathic and 1 combined post-surgical and diabetic. The median follow-up was 23M (range 12–31). All procedures were successfully completed. One patient experienced delayed bleeding from gastric ulceration, which was successfully treated endoscopically; all remaining patients recovered uneventfully. Treatment success was achieved in 8/9 patients (88.9%) at 3, 6 and 12M and in 3/4 (75%) at 24M. The mean GSCI decreased from 3.16 to 0.86 (p=0.008), 0.74 (p=0.008), 1.07 (p=0.008) and 1.31 (p=0.11) at 3, 6, 12 and 24M after the procedure. The Quality of Life Index improved from the baseline value of 77 (range 48−102) to 113 (86–138, p=0.03) and 96 (50–124, p=0.4) at 12 and 24M. In patients with treatment success, no recurrences have occurred so far. GES improved/normalized in all the patients. Conclusion: G-POEM was effective in 88.9% of patients with refractory GP and the effect seems to be long-lasting.

Název v anglickém jazyce

Per-oral endoscopic pyloromyotomy (G-POEM) for the treatment of gastroparesis - a pilot single-centre study with mid-term follow-up

Popis výsledku anglicky

Introduction: Endoscopic pyloromyotomy (G-POEM) is an emerging therapeutic method for the treatment of gastroparesis (GP). So far, only limited case-series suggesting its effectivity have been published. The aim of our study was to assess the effectivity of G-POEM in patients with refractory GP. Methods: Consecutive patients with severe and refractory GP were offered the procedure. An abnormal gastric emptying study (GES) was necessary for inclusion. The main outcome was treatment success defined as a decrease of the total GSCI symptom score by at least 40% from baseline at 3, 6, 12 and 24 months. Results: G-POEM was performed in 9 patients (5 women, mean age 56.3): 5 post-surgical, 2 diabetic, 1 idiopathic and 1 combined post-surgical and diabetic. The median follow-up was 23M (range 12–31). All procedures were successfully completed. One patient experienced delayed bleeding from gastric ulceration, which was successfully treated endoscopically; all remaining patients recovered uneventfully. Treatment success was achieved in 8/9 patients (88.9%) at 3, 6 and 12M and in 3/4 (75%) at 24M. The mean GSCI decreased from 3.16 to 0.86 (p=0.008), 0.74 (p=0.008), 1.07 (p=0.008) and 1.31 (p=0.11) at 3, 6, 12 and 24M after the procedure. The Quality of Life Index improved from the baseline value of 77 (range 48−102) to 113 (86–138, p=0.03) and 96 (50–124, p=0.4) at 12 and 24M. In patients with treatment success, no recurrences have occurred so far. GES improved/normalized in all the patients. Conclusion: G-POEM was effective in 88.9% of patients with refractory GP and the effect seems to be long-lasting.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30219 - Gastroenterology and hepatology

Projekt

<a href="/cs/project/NV17-28797A" target="_blank" >NV17-28797A: G-POEM v léčbě refrakterní idiopatické a diabetické gastroparézy – randomizovaná a kontrolovaná „sham“ studie</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Rozhledy v chirurgii

ISSN

0035-9351

e-ISSN

—

Svazek periodika

99

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

8

Strana od-do

116-123

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85104764684